← Banking With Billy News

Atossa Therapeutics said it is advancing the EVANGELINE trial in premenopausal women with ER-positive breast cancer. The study tests (Z)-endoxifen with ovarian

BWB News TV • 2026-08-28 14:16 UTC • By Billy Odell Tucker-Robinson
Atossa Therapeutics said it is advancing the EVANGELINE trial in premenopausal women with ER-positive breast cancer. The study tests (Z)-endoxifen with ovarian
Atossa Therapeutics said it is advancing the EVANGELINE trial in premenopausal women with ER-positive breast cancer. The study tests (Z)-endoxifen with ovarian function suppression and uses biomarkers including Ki-67 to gauge response.
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly